Condition Focus: Knee Osteoarthritis — Dual Oxidative Stress and Inflammatory Cytokine Reduction
Most PBM studies measure either oxidative stress markers or inflammatory cytokines. This study from Yamada and colleagues measured both — simultaneously, in the same animals, at both local (joint) and systemic (blood) levels. The dual-measurement, dual-site design provides the most comprehensive picture available of PBM’s effects on the oxidative and inflammatory pathways that drive joint disease.
Using 904 nm superpulsed laser in a monoiodoacetate (MIA)-induced knee OA model, the researchers tested three energy densities (6, 12, and 18 J/cm²) and measured oxidative stress markers, antioxidant capacity, pro-inflammatory cytokines, and pain behaviours. The results showed reductions in oxidative stress and inflammatory cytokines at both local and systemic levels, along with pain reduction and increased antioxidant capacity.
The systemic effects are significant: PBM applied to one joint reduced inflammatory markers in the bloodstream, not just at the treatment site. This suggests that PBM’s anti-inflammatory and antioxidant effects propagate beyond the local tissue, potentially addressing the systemic inflammatory burden that gout patients carry even between flares.
For gout, the dual mechanism is directly relevant. Gout is simultaneously a condition of excessive oxidative stress (mitochondrial ROS driving NLRP3) and excessive inflammation (IL-1β, TNF-α, IL-6 driving the clinical flare). An intervention that addresses both simultaneously — and does so both locally and systemically — is mechanistically better matched to gout pathophysiology than a single-target drug.
G.O.A.T. for Gout Alignment:
While this study used 904 nm superpulsed (vs. the G.O.A.T.’s 660 nm + 850 nm continuous wave), the oxidative stress and cytokine reduction pathways operate across the NIR range. The dual local + systemic effect supports the rationale for regular maintenance PBM sessions: each treatment addresses both the local joint environment and the systemic inflammatory burden of chronic hyperuricaemia.
Link to original research here
Editor’s note: The oxidative stress pathway demonstrated here connects to the ROS-NLRP3 axis in gout reviewed in Kim et al 2023 and Braga et al 2017. The context-dependent ROS reduction in stressed cells is explained in Hamblin 2018. The inflammatory cytokines reduced here (at the protein level) are confirmed at the meta-analytic level by Nambi 2021. The dose-comparison approach parallels Al Musawi et al 2026.
Related Articles
- Mechanism of NLRP3 Inflammasome Activation in Gout – Kim et al 2023
- Soluble Uric Acid Activates the NLRP3 Inflammasome – Braga et al 2017
- Mitochondrial Redox Signaling and PBM – Hamblin 2018
- LLLT Effects on Inflammatory Biomarkers in OA: Meta-Analysis – Nambi 2021
- PBM for Reducing RA Using Different Energy Densities – Al Musawi et al 2026
Key Takeaways
- Dual mechanism: oxidative stress reduction AND inflammatory cytokine suppression in one study
- LOCAL + SYSTEMIC effects — PBM applied to one joint reduced bloodstream markers
- Antioxidant capacity increased — active enhancement, not just ROS suppression
- Gout is simultaneously high-ROS and high-inflammation — dual mechanism is ideal match
Study Overview
| Study Type: | Controlled animal study (dose-comparison) |
| Wavelength(s): | 904 nm superpulsed |
| Treatment Protocol: | 6, 12, 18 J/cm²; MIA-induced knee OA model |
| Sample Size: | Multiple rat groups (3 dose + controls) |
| Primary Outcome: | Oxidative stress↓, cytokines↓, antioxidant↑, pain↓ — local AND systemic |
Full Citation
Yamada EF, Bobinski F, Martins DF, et al. (2020). Photobiomodulation therapy in knee osteoarthritis reduces oxidative stress and inflammatory cytokines in rats. Journal of Biophotonics, 13(1), e201900204. View Publication
